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ABSTRACT
Weight management is integral to cardiovascular risk reduction. However, minimal weight loss
is achieved during participation in many cardiac rehabilitation (CR) programs. The objective of the
present study was to establish if brief interventions by a registered dietitian (RD) during cardiac
rehabilitation sessions improved the health status of patients with cardiovascular disease. An RD
provided individualized nutrition counseling, answered nutrition questions, and reviewed weekly
progress in a CR program for a four-month period. At baseline and upon completion of 19 CR
sessions, nutrition knowledge was assessed using a 38-question test, and body weight was measured.
Upon completing CR, patients rated the degree at which they were making healthier food choices
and how much they liked having an RD assessable during CR. After four months, the exercise
physiologists (EPs) rated the value of having an RD in CR. Outcomes were collected on every
patient who completed CR during this period, and values were compared to outcomes of patients
who completed CR during the same timeframe one year earlier. Both groups received instruction
regarding the traditional CR exercise program and four 45-minute weekly group nutrition education
sessions. Forty-nine patients (36 males) completed CR with the RD present. Mean nutrition
knowledge test scores improved from 59 ±1 4% to 72 ± 14%, (p = < .001). After completing CR,
patients reported making healthier food choices 8.1 ± 1.2 out of 10 on a Likert scale. Additionally,
patients related the helpfulness of having an RD available to answer their nutrition questions 8.7 ±
4.8 out of 10. The group of patients who had an RD present during CR had a mean weight loss of
1.48 ± 7.1 lbs (range -18.8 to 16.4 lbs) when compared to the group who did not have access to an
RD. Ten patients were referred for individual nutrition counseling with an outpatient RD. Exercise
physiologists rated the value of having an RD as part of the health care team a 9.8 out of 10. There
was a trend towards greater weight loss in the group of patients who had access to an RD in CR.
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Chapter 1
Introduction
Introduction
Approximately seventy-one million Americans have cardiovascular disease (CVD) during their
lifetime, of whom 27 million are estimated to be 65 years of age and older (1).

Cardiovascular disease

claims the lives of over 40% of the nearly 2.4 million Americans who die each year and is ranked as
America’s number one killer of older men and women. Established coronary heart disease (CHD) is a
major form of CVD and is a risk factor for the occurrence of subsequent coronary events and death
(1,2). Secondary prevention is essential in the treatment of CHD and has been proven to be effective
in reducing the incidence of associated cardiovascular risk factors (3).
Cardiac rehabilitation (CR) was designed in the 1960s and initially focused on increasing aerobic
capacity and exercise tolerance in the aftermath of prolonged hospitalization or de-conditioning after
a myocardial infarction (4). The primary types of patient diagnosis that are found in a typical
outpatient CR center include CHD, coronary artery bypass grafting (open heart surgery),
percutaneous transluminal coronary angioplasty (stent placement), and valvular heart surgery (valve
replacement).
In 1994, the American Heart Association (AHA) stated that CR programs should include both a
multifaceted and multidisciplinary approach to facilitate cardiovascular risk reduction. Programs that
consist solely of exercise training are not recognized today as true CR programs (5,6). The AHA
and the American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR)
recognize that all cardiac rehabilitation/secondary prevention programs should contain specific core
components that aim to optimize cardiovascular risk reduction, foster healthy behaviors, and
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reinforce compliance with these behaviors with consistent reduction of disability while promoting an
active lifestyle (5,7).
Obesity is becoming a global epidemic and is now considered to be an independent risk factor
for CVD. Presently, 70-88% of patients diagnosed with CVD are overweight (8). According to
the AHA, obese people are at greater risk of developing one or more serious medical conditions,
such as hypertension, hyperlipidemia, diabetes, heart disease, and stroke. Consequently, the AHA
has reclassified obesity as a major CVD risk factor (9).

The National Heart, Lung and Blood

Institute also identified obesity as a major health problem and stated it must be evaluated and treated
in CR centers (4). Overweight and obesity are assessed by measurement of body mass index (BMI)
(10,11).
Overweight patients who participate in CR programs around the country have been shown to be
unsuccessful in losing weight (9). Cardiac rehabilitation programs are typically initiated 1 to 3
months after a patient experiences a coronary event and are provided in three phases to help ensure
a patient’s safe recovery and instill permanent lifestyle modifications. Nutrition education and
counseling have become key components of CR (5), and medical nutrition therapy have been shown
to improve CHD risk factors (12). Immediately after a patient is diagnosed with CHD or has
successfully completed CVD surgery is an opportune time for a registered dietitian (RD) to discuss
weight loss and lifestyle changes with patients and with people who are closely involved in the
patient’s life (8).
Objective of the Study
The objective of this study was to establish whether brief intervention by a RD during CR
exercise sessions will improve the health status of patients who have been diagnosed with CVD.
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Chapter 2
Literature Review
The success of CR/secondary prevention programs is dependent on the clinical attributes of the
participants. Audelin et al. (13) examined the changes in the profile of individuals who entered CR
from 1996 to 2006. They found that the age of the individual increased from 60.6 to 63.4 years, and
the proportion of patients 75 years or older increased by 59%. The proportion of women, initially
25%, did not change. Entry weight increased from 84.7 to 88.5 kg. Overtime, the weight of patients
with a diagnosis of obesity, diabetes, or hypertension increased 35%, 52% and 48%, respectively.
Patients with elevated blood pressure levels did not show changes in their blood pressure. Total
cholesterol, triglycerides and low-density lipoprotein cholesterol (LDL-C) decreased by 20%, 35%
and 27%, respectively, whereas high-density lipoprotein cholesterol (HDL-C) increased by 12%.
The use of all evidenced-based cardiovascular drugs increased significantly, particularly due to the
use of statins (from 25% to 77%). It was concluded that CR patients are now older, more frequently
present with features of metabolic syndrome, and are relatively less fit. However, they have also
shown an increase in statin drug use over the past 10 years and this has contributed to a marked
improvement in serum lipid management (13).
Coronary heart disease (CHD) is a major cause of morbidity and mortality and is related to
adverse health events worldwide (14). Elevated LDL-C and reduced HDL-C concentrations are well
recognized as CHD risk factors, with recent evidence supporting the benefits of intensive LDL-C
reduction of CHD risk (15). According to the Third Report of the National Cholesterol Education
Program Adult Treatment Panel (NCEP ATP III) (49), high risk individuals (those with preexisting
CHD or CHD risk factors) require aggressive lipid lowering treatment to achieve the stringent LDL-
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C goals. Statins have assumed the central role in this arena because of their superior ability to reduce
LDL-C by inhibiting the rate of cholesterol biosynthesis and reduced CHD events (15).
Results of the United Kingdom Heart Protection Study (HPS) suggest those individuals with
CHD or who are at high risk and have concentrations of LDL-C >100mg/dl could benefit from
drug therapy. However, implementing lipid management guidelines has proven to be a difficult task.
The Lipid Treatment Assessment Project (L-TAP) was a study of approximately 5,000 patients in
the United States, including 1,400 individuals with CHD who were treated with lipid-lowering
therapy for ≥3 months. In this study it was found that most of the patients did not achieve NCEP
ATP III goals. In patients with CHD, only 18% achieved LDL-C concentrations ≤100 mg/dl. This
study suggested that the patients were under-treated with statins, and in the future, statins need to be
administrated at a higher dosage initially to be more effective (16,17).
Current cholesterol lowering therapies include use of statins, bile acid sequestraints, niacin, plant
stanols, and combination therapy:
Statins: Statins are by far the most powerful, consistent, and best tolerated agents for lowering
LDL-C. They have been shown to lower LDL-C up to 52-55% when used at the highest dose of 80
mg/day. Possible side effects of statin use may include myalgia (muscle weakness) and significant
elevations of hepatic enzymes, which could result in having to stop the use of the statin or reduce
the dose (16).
Bile acid sequestrants: These are gut-acting, non-absorbable agents that have been used for the past
30 years. They are only moderately effective in lowering the LDL-C levels (15-25%). The major
barrier to their use is the amount required, palatability, and gastrointestinal side-effects (gas, bloating,
and constipation) (16,18).
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Niacin: Niacin is the oldest lipid-lowering drug, dating back to the 1950s. It has demonstrated
moderate LDL-C reducing ability (10-20%). Niacin has proven to be a powerful agent for
increasing HDL-C from 10-15% to as much as 20-30% depending on the dosage. In addition,
niacin is also effective in lowering triglycerides. The major drawback of this agent is patient
compliance and initial side effects, which include flushing and skin irritation, mainly of the neck and
face. The side effects can often be overcome in most patients by gradually increasing the dosage
and instructing patients to take niacin with food and a low dose of aspirin. For patients requiring
additional LDL-C reduction to meet suggested goals, a combination of niacin and a statin is a good
option and may even be more effective in arresting or reversing atherosclerosis than the use of
statins alone (16,19).
Plant Stanols: Plant stanols are ester derivatives of plant sterols that can decrease LDL-C by about
10%. These compounds are generally given as dietary supplements such as stanol-containing
margarines, juices, breads, and chews. Plant stanols are more popular in Europe than in the United
States and are generally well tolerated (16,20).
Combination therapy: Combination statin therapy with any of the above lipid-lowering agents can
assist patients in attaining LDL-C goals. If maximum dose of a statin fails to reduce LDL-C to target
concentrations, a bile acid sequestraint may also be added to the drug regimen. This combination
can yield an additional 10-12% decrease in LDL-C concentrations (16,21). A study conducted by
Kashyap (21) and colleagues showed a 47% LDL-C reduction, accompanied by a 30% increase in
HDL-C concentrations and a 42% decrease in triglyceride concentrations when patients were
prescribed niacin and a statin that was titrated from a dose of 500 mg niacin/10 mg lovastatin to
2000 mg niacin /40 mg lovastatin.
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Type 2 diabetes mellitus is becoming more prevalent in the United States and has been shown to
increase the risk of cardiovascular disease (22). A patient’s poor understanding of diabetes is
believed to impede appropriate self-management of the disorder, thus accelerating cardiovascular
complications. A study conducted by Sanchez et al. (23) investigated the relationship between
patients’ Diabetes-Related Knowledge (DRK) and measurements of risk factor control and cardiac
outcomes. Clinical outcomes data were obtained 6 months after enrollment. Years of education
and DRK assessment scores were found to be moderately correlated (r = 0.496, p < 0.0001).
Glycosylated hemoglobin A1C, LDL-C and body mass index showed no correlation with DRK
assessment scores, even after multivariable adjustment for differences in age, race, insulin
requirement, duration of diabetes, and years of education. Rate of myocardial infarction was not
significantly different between groups of patients stratified by DRK assessment scores (high vs. low
scoring groups). The study concluded that new strategies must be developed to translate
understanding of the disease into better risk modification among patients who have diabetes.
A study conducted by Martin and colleagues (24) evaluated the effectiveness of a
multidisciplinary team that provide both education and medication management in a group setting
for cardiac risk reduction in patients with diabetes. Forty-one patients attended four 1.5-hour
diabetes self-management education classes that were provided by a multidisciplinary team. The
team consisted of a pharmacist, nurse educator, dietitian, physical therapist, and a social worker.
Four 1-hour group medication adjustment sessions were also provided by the pharmacist. The
patients showed improvements in all parameters after the intervention. Significant reduction in
glycosylated hemoglobin A1C (-1.5 %± 1.0%) (p < .01) and diastolic blood pressure (-5 mg Hg)(p <
.01) occurred.
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Hypertension is a common disease that affects approximately 1 billion people worldwide (25).
Hypertension is defined as a systolic pressure above 140 mmHg and /or a diastolic pressure above
90 mmHg (26). The Seventh Report of the Joint National Committee (JNC-7) on Prevention,
Detection, Evaluation, and Treatment of High Blood Pressure defined a new entity, “prehypertension,” in order to reflect the growing evidence that systolic blood pressure (SBP) values
between 120-139 mmHg and diastolic blood pressure (DBP) values between 80-89 mmHg are
associated with increased cardiovascular risk (26,27). It is estimated that an additional 30% of the
adult population fall into this category (26,28). Coronary artery disease is the most common form
of target-organ damage and most common cause of mortality associated with hypertension (26).
There have been several studies that have examined the relationship between hypertension and
coronary events, and some studies have included “pre-hypertension” range. Sipahi and colleagues
(26) were the first research group that showed the impact of pre-hypertension on coronary events.
They conducted the CAMELOT (Comparison of Amlodipine Versus Enalapril to Limit
Occurrences of Thrombosis) trial. This study demonstrated a continuous relationship between SBP
and the progression of coronary atherosclerosis over a broad range of blood pressures extending
from 100 mm/Hg to the hypertensive range. They concluded that in a patient population with well
controlled BP and coronary artery disease, a higher SBP level was associated with an increased
progression of coronary atherosclerosis. This study suggested that for patients with coronary artery
disease, the optimal BP goal may be lower than < 140/90 mm Hg level.
It is known that the risk of cardiovascular disease increases in the presence of endothelial
dysfunction. Both hyperlipidemia and hypertension are significant risk factors of CAD, and when
these two conditions are present, the risk of CAD more than doubles (29,30). There is growing
evidence suggesting that hyperlipidemia causes impairment in vasorelaxation in both animals and
humans (29,31). Brett et al. (32) found a positive correlation between the increase in diastolic
7

blood pressure during exercise and the serum concentration of total cholesterol, but they did not
find this correlation with an increase in systolic blood pressure. Kubozono (29) examined the
relationship between serum cholesterol and blood pressure during exercise in patients with CAD
and found that patients with CAD had an increase in diastolic blood pressure during exercise that
was significantly higher in patients with hypercholesterolemia. During normal exercise, systemic
vascular resistance decreases as exercise becomes more intense in order to allow more blood to flow
to the exercising muscles. In normal subjects it is known that diastolic blood pressure, which is a
parameter determined by cardiac output and peripheral vascular resistance, does not significantly
change during exercise in spite of a large increase in systolic blood pressure. Kubozono (29)
proposed that impaired vasodilator capacity in patients with hypercholesterolemia may have resulted
in a higher vascular resistance, causing high diastolic blood pressure during exercise. This suggested
that patients with hyperlipidemia were at a higher risk of developing hypertensive complications.
Weight management should be an essential component in CR programs since most patients with
CHD are overweight. However, only minimal weight loss occurs with participation in a traditional
CR program (8). Ades et al. (33) reported that body weight should be reduced initially by at least
10% from baseline at a rate of 1 to 2 pounds per week over a period of 6 months in CR patients.
Successful short-term weight loss, however, is not always achievable since targeted weight reduction
interventions are not available as a core component of traditional CR programs (8,34,35).
It has been proposed that the reason for minimal weight loss noted among patients participating
in CR is that there is typically only a modest increase in exercise-related caloric expenditure, and this
is often combined with inadequate caloric reduction. The exercise-related caloric expenditure that is
usually prescribed during CR is only 720-800 kcal per week and is, therefore, unlikely to lead to
significant weight loss over a 2-3-month period (37,38). As CR patients change their diet by

8

lowering saturated fat and sodium consumption, or increasing fiber, there is generally no purposeful
decrease in total caloric intake (39).
Savage and Ades (40) acknowledge that there has been an increased focus of CR protocols on
coronary risk factors (CRF) and weight reduction, and his team has suggested a new approach to
managing obesity in CR. In their study, patients were instructed on how to count calories and keep
dietary food records. Each week after CR, a one-hour-long education session was conducted by a
nurse or dietitian coordinator. During these sessions, patients were specifically trained in behavioral
weight loss techniques. Various topics covered during weekly meetings included goal setting,
stimulus control, assertiveness training, “heart healthy” nutrition, stress management, emotional
eating, and relapse prevention. Over a 3-month period, the combination of behavior modification,
weight loss counseling, and standard CR exercise resulted in a mean weight loss of 5 kilograms (11
pounds), a 4-centimeter (1.57 inch) reduction in waist circumference and improvement in serum
lipid concentrations. Savage and Ades (40) have suggested that the proven effectiveness of weight
loss behavior interventions should be considered along with exercise in all CR programs. Exercise
interventions must be assessed relative to calories expended per session per week. Furthermore,
physical activity outside of structured CR programs should be encouraged, and compliance should
be assessed.
The role of nutritional intake and the contributions of an RD in the outpatient CR setting are
specified in practice guidelines (40). Medical nutrition therapy (MNT) is an integral component of a
comprehensive management and treatment program that focuses on decreasing coronary artery
disease (CAD) risk factors (25, 41, 42, 43). One of the first published studies that dealt with the
analysis of nutrition services in CR was conducted by Cavallaro and colleagues (2). They randomly
surveyed 250 United States outpatient clinics nationwide to describe the type and amount of
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nutrition services offered in CR programs. It was determined that more nutrition services were
offered in CR programs that had an RD working in the program than in those CR programs that did
not. The clinical expertise of an RD was recognized as an important component in a CR setting.
Overall, RD’s were the preferred source for one-on-one counseling and nutrition information.
However, many CR clinics reported that other healthcare professionals were performing nutrition
services because of inadequate funding. Although nutrition education and RD support are highly
regarded in CR programs, research has shown that for RD’s to be successful in these settings and to
be utilized in a greater capacity, the RD must strive to be seen as a full and active member of the CR
team. It is recognized that other healthcare professionals can learn nutrition-related skills, but
presently RD’s are the only identifiable group with standardized education, clinical training, and
national credentials.
Lemon and colleagues (43) have shown positive outcomes in adults receiving nutrition
intervention from an RD for patients with type 2 Diabetes. Patients reported improvements in their
diet/lifestyle and felt very knowledgeable and motivated after consultation with an RD.
Clearly, diet and lifestyle modifications can play key roles in both the prevention and treatment of
CVD. With the surge of unregulated nutrition messages it is understandable that the American
public is confused and often makes poor decisions with respect to diet choices. In 2006, the
American Heart Association (AHA) published the diet and lifestyle recommendations for
cardiovascular disease risk reduction in an attempt to put balance and perspective on healthy
behaviors. The recommendations include:





Balance calorie intake and physical activity to achieve or maintain a healthy body weight.
Consume a diet rich in vegetables and fruit.
Choose whole-grain, high-fiber foods.
Consume fish, especially oily fish, at least twice a week.
10



Limit intake of saturated fat to < 7% of energy, trans-fat to < 1% of energy, and cholesterol
to < 300 mg per day by:
o Choosing lean meat and vegetable alternatives
o Selecting fat-free (skim), 1%-fat and low fat dairy products
o Minimizing intake of partially hydrogenated fats






Minimize your intake of beverages and foods with added sugars.
Choose and prepare foods with little or no salt.
If you consume alcohol, do so in moderation.
When you eat food that is prepared outside of the home, follow the AHA Diet and Lifestyle
Recommendations (44)

The aim of these recommendations is to decrease CVD risk through improvements in diet and
lifestyle. They were formulated to support the AHA goals for CVD prevention by getting patients
to aim for healthful body weight, recommended concentrations of LDL-C, HDL-C, triglycerides,
normal blood pressure, and normal glucose concentration. Goals also focused on having patients be
more physically active and avoid the use of and exposure to tobacco products. The 2006 diet and
lifestyle recommendations are not presented as a “diet” plan but as something that can be thought
of as a lifestyle prescription to promote cardiovascular health (43).
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Chapter 3
Research Design and Methodology
Patients
Ninety-two patients who entered the outpatient CR program at the University of Michigan
Health System Preventive Cardiology Clinic at Domino’s Farms (Ann Arbor, Michigan) were
involved in the present study. All patients attended the CR orientation and were treated in one of
two ways. The control group (Group A) consisted of 43 patients (33 males and 10 females), who
participated in Year 1 of the study and did not have an RD present during their CR. The
experimental group (Group B) consisted of 49 patients who participated in Year 2 of the study and
who had an RD present during their CR. This group included 36 males and 13 females. All patients
who participated in this study had clinical confirmation of having had a coronary event during the
previous 3 months or were at high risk for experiencing a coronary event in the future.
The present study was approved by the University of Michigan Medical School Institutional
Review Board (IRBMED) and by the Eastern Michigan University IRB. All patients were provided
informed consent prior to participation in this study.
Experimental Design
The present study was conducted over a two-year period. Prior to starting the CR program, all
patients attended a two-hour orientation which was directed by an exercise physiologist (EP). The
EP reviewed the program with all patients and provided them with an initial Health History
Questionnaire (HHQ) that they completed during orientation. Comprehensive physical
examinations and serum analysis were also completed at this time. Both groups of patients
completed 18 prescribed CR sessions, over a period of six to nine weeks.
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After initial testing and training was completed, Group A patients who entered CR between
October 2003 and January 2004 followed the traditional CR protocol. Group B patients entered CR
between October 2004 and January 2005. The Group B patients had a research RD present during
their CR sessions. Treatments provided to patients in Groups A and B are shown in Table 1.
Table 1 A comparison of treatments/questionnaires/tests provided to control (Group A) and
experimental (Group B) cardiac rehabilitation patients who participated in a 6-9 week cardiac
rehabilitation program over a 2 year period.
Group A

Group B

1. Comprehensive physical exam and pre- and
post-serum analysis

X

X

2. 6-9 week aerobic and resistance training

X

X

3. Weekly class instruction; nutrition, exercise,
and stress management
4. Opportunity for one-on-one nutrition education
sessions with a dietitian
5. Access to dietitian during CR exercise
Sessions

X

X

X

X
X

6. 3-day food analysis at the start of CR

X

7. Pre- and post-CR Nutrition Knowledge Test

X

8. CR Graduation Questionnaire

X

9. Exercise physiologists evaluation of RD

X

The exercise component of the CR session consisted of both aerobic and resistance training.
The CR team provided weekly class instruction that focused on improving the patients’ nutritional
intake and exercise patterns while decreasing their stress levels. The initial nutrition training focused
on the improvement of the following six dietary behaviors that have been associated with healthy
eating: (a) reading labels, (b) eating healthy when dining out (restaurants/cafeterias/takeout), (c)
consuming desired food portion sizes, (d) choosing healthy fats in appropriate amounts, (e)
increasing soluble fiber intake by consuming fruits, vegetables, legumes, lentils, oats and oat bran,
13

and (f) lowering dietary sodium intake. If staff members decided that additional counseling was
needed, patients were provided with a referral for a one-on-one nutrition or stress management
counseling session.
Anthropometric Measurements / Vital Signs
Anthropometric measurements were obtained from all patients throughout the study. Each
patient’s height and body weight were measured while he/she were wearing clothing and shoes.
Height was measured using a stadiometer and was rounded off to the nearest 1/8 inch. Weights
were measured using a calibrated Scaletronix 845010 digital scale and were recorded to the nearest
pound. Subsequent body weight measurements were made at the start of each CR session. A
person’s BMI is normally calculated to determine levels of body fat. Overweight is defined as a BMI
of 25.0 to 29.9 kg/m2, whereas obesity (class 1) is 30.0-34.5 kg/m2, obesity (class 2) is 35-35.9
kg/m2, and extreme obesity is defined as a BMI of 40 or greater kg/m2 (10, 11). Measurement of
body mass index was calculated using the following formula:
BMI=kg/m2 (11)
At each CR session, the patient’s pre- and post-blood pressure measurements were also obtained,
using a Critikon Vital Answers dura cuff 2791.
Biochemical Measurements
Fasting serum blood samples were collected and analyzed by the Preventive Cardiology OutPatient Pathology Laboratory (University of Michigan Health Systems; Ann Arbor, Michigan).
Blood samples were drawn by a trained phlebotomist after an overnight fast of at least 10-12 hours
and were tested within 10-15 minutes after collection. Plasma cholesterol and triglyceride
concentrations were measured using enzymatic colorimetic methods (46,47). HDL cholesterol was
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separated from LDL and very-low density lipoprotein cholesterol by precipitation and was then
measured using enzymatic colorimetric methods (46,47). In samples where triglycerides were less
than 400 mg/dl (4.5 mmol/L), LDL cholesterol was calculated using the Friedewald equation (48).
If triglycerides were over 400 mg/dl, the sample was sent to the University of Michigan Health
System Laboratory for further testing.
RD Encounter Form:
This form was created by the researcher to document interactions between the researcher and the
CR patient when they were actively engaged in their CR session. This tool was useful to the RD to
monitor weekly interactions with individual patients’ and recording their nutrition concerns and
questions, lifestyle changes and challenges, and weekly progress (Appendix A).
Patient Nutrition Knowledge:
Upon initiation and completion of the CR program, patients were asked to complete a Nutrition
Knowledge Test (NKT) to determine improvement of each patient’s nutrition knowledge. This
form was developed by facility staff members to assess patient knowledge in various other programs
at the PC Clinic (Appendix B).
3-Day Food Record:
At the start of their CR program, all patients’ nutrition intakes were assessed using their 3-day
food record. Patients were asked to provide a detailed description of the type and quantity of food
they consumed over a 3-day period. The completed food records were reviewed with the patient,
collected, and analyzed using the Nutritionist ProTM First Databank software (2006). Individual
dietary feedback regarding healthy nutritional habits patterned after the National Cholesterol
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Education Program Adult Treatment Panel III (NCEP ATP III) criteria was provided by the RD
when patients came to their CR exercising sessions (Appendix C).
Nutrition and Cardiac Rehabilitation Questionnaire:
Prior to this study, an RD was not available to patients during CR. A short questionnaire was
developed, using a 10-point Likert scale, and given to patients upon completion of their CR
program. The questions were designed to determine if the CR patients (a) valued having access to
an RD while participating in CR and (b) were confident in making healthier food choices (Appendix
D).
Exercise Physiologists Evaluation of RD Support
At the completion of this study, the researcher provided each CR EP with a questionnaire asking
him/her to evaluate the RD researcher’s effectiveness as member of the CR program (Appendix E).
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Chapter 4
Patient Demographics
A comparison of background characteristics of the men and women who participated in the
present study is shown in Table 2.
Table 2: Baseline characteristics of cardiac rehabilitation patients who did not have the RD support
(Group A) and patients who did have RD support (Group B)

Demographics
Age (years)
BMI (kg/m2)
Gender
Males
Females
Ethnicity
African American
Asian
Caucasian
Other
Marital Status
Single
Married
Divorced
Widowed
Education
8th grade of less
12th grade
4 or more years of college
Occupational status
Active
Retired
Diagnosis
Coronary Artery Disease
Hypertension
Diabetes
Medication
Lipid lowering
Anti-diabetic

Group A (n=43)
Mean±SD
Range
64.1±10.6
31.9-78.3
29.2± 5.3
22.6-46.5
N
%

Group B (n=49)
Mean±SD
Range
60.9±11.4
35.7-87.4
30.3± 6.9
18.5-52.1
n
%

33
10

76.7
23.2

36
13

73.5
26.5

5
0
38
0

11.6
0
88.3
0

3
3
42
1

6.1
6.1
85.7
2.0

2
34
1
6

4.6
79.0
2.3
13.9

4
39
4
2

8.1
79.5
8.1
4.0

0
10
33

0
23.2
76.7

2
15
32

2.0
30.6
65.3

21
22

48.8
51.1

25
24

51.0
48.9

42
33
14

97.6
76.7
32.5

45
42
15

91.8
85.7
30.6

36
12

83.7
27.9

45
13

91.8
36.5

aSD=standard deviation bTo convert mg/dl cholesterol to mmol/L, multiply mg/dL by 0.02587 cTo convert mg/dL triglycerides to
mmol, multiply mg/dL by 0.001129.
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No significant differences in characteristics were observed between Group A and B patients
at the beginning of this study. The majority of patients in both groups were male (76% of Group A
and 73% of Group B). Group A patients had a mean age of 64.1±10.6 years, whereas those in
Group B had a mean age of 60.9 ±11.4 years. Drug therapy that focused on lipid lowering
medications was received by 84% of Group A and 92% of Group B patients. Incidence of type 2
diabetes occurred in 12 patients in Group A and 13 patients in Group B.
Serum Biomarkers
Data presented in Table 3 show that serum lipid concentrations (total cholesterol, triglycerides,
HDL-C and LDL-C) for Groups A and B improved slightly, but there was no significant difference
between Groups A and B at the end of CR.
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Table 3 Pre- and post-cardiac rehabilitation patient of serum lipids, glucose, and hemoglobin A1C concentrations, as well as body weight and
blood pressure.

Pre CR
Mean±SD
Total
Cholesterol
mg/dL
Triglycerides

Control

Intervention

n = 43

n = 49
Post CR

Range

P value

Mean±SD

Range

Pre CR
Mean±SD

Post CR

Range

Mean±SD

Range

P value

163.9 ± 9.4

84 – 262

162.9 ± 35.3

93 - 230

.591

151 ± 39.9

70 - 255

142.2 ±35.0

80 - 225

.224

148.9 ± 97.6

41 – 594

141.2 ± 81.9

47 – 505

.241

130 ± 93.5

36 - 614

118.7 ±72.4

37 - 433

.280

HDL-C mg/dL

48.0 ± 11.5

31 – 78

49.4 ± 13.7

29 – 96

.506

44.8 ± 13.9

20 - 81

47.7±15.6

19 - 93

.260

LDL-C

91.2 ± 30.6

36 – 178

85.2 ± 27.1

33 – 139

.160

74.3 ± 30.0

20 - 155

71.7±28.5

18 -151

.218

Glucose

109.2 ± 28.0

65 – 202

98.9 ± 24.6

61 – 163

.001

104.6±18.8

80 - 171

115.4±29.4

77 - 99

.029

HgbA1c

7.6 ± 1.7

5.8 - 11.0

7.0 ±. 75

6.4-8.7

.000

7.2 ± 2.0

5.2-13.0

6.9 ± 1.0

5.4- 8.6

.000

190.2 ± 5.3

140.1-

.179

196.9± 6.1

Weight

191.7 ± 5.7

135.4- 333.4

114.9-324.7

194.4 ± 6.0

320.0

112.0332.2

.009

18.1-52.3

.009

BMI(kg/m2)

29.2 ± 5.3

22.6 - 46.5

29.0 ± 4.8

22.6-44.6

.183

30.6 ± 6.9

18.6-52.2

29.9 ± 6.9

Rest SBP

125 ± 20.7

92 -172

111.0 ± 17.9

86 – 156

.000

122.0± 19.9

90 -174

114.9 ± 17.4

80 -160

.005

Rest DBP

73.9 ± 9.9

54 -100

63.5 ± 9.1

44 – 84

.000

70.0 ± 9.6

50 - 90

65.0 ± 7.8

48 - 86

.000
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Anthropometric Measurements
Group B patients had a significant (p ≤ .001) mean weight loss of 2.5±6.4 pounds (range -10.6 to
19.5 pounds). In comparison, Group A patients had an insignificant mean weight loss (p ≤ 0.1)of
1.48±7.1 pounds (range -18.8-16.4), (Figure 1).

Figure 1 Weight loss experienced by cardiac rehabilitation patients at completion of rehabilitation
with and without an RD present
The BMI of Group B patients improved significantly (p≤ 0.009), whereas Group A patients did not
show a significant change (p≤0.018). Group A patients showed an 8.8% decrease in resting SBP and
an 8.5% decrease in resting DBP. Group B patients also showed significant improvement in their
blood pressure (resting SBP decreased 9.4% and resting DBP decreased 9.2%).
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Patient Nutrition Knowledge
As illustrated in Figure 2, Group B patients showed a noticeable improvement in nutrition knowledge
(10% score increase) by the end of the study.

No. of correct answers

35

b

30

a
25
20
15
10
5

Pre CR

Post CR

0

Figure 2 Nutrition Knowledge Test results of cardiac rehabilitation patients pre- and postrehabilitation
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Dietary Intake at the Start of CR
Dietary intake of Group B patients was assessed at baseline using data from the 3-day food diaries.
The average daily caloric energy intake was 1826 calories. The macronutrient energy intake breakdown
was as follows: 49.5 % carbohydrates, 17 % protein, 31.5% fat, and 4.1 % saturated fat. The data
from the 3-day food records suggested that an adequate amount of fiber, sodium, and Vitamin C were
consumed. Patients exceeded the Recommended Daily Intake (RDI) of total fat, saturated fat, and
dietary cholesterol and consumed inadequate amounts of calcium. The summary of nutrient intake is
shown in Table 4.
Table 4 3-Day Food Record nutrient intake of cardiac rehabilitation (n=29)
Nutrient
Total calories

Mean±SD

Range

1827 ± 538

686 – 2614

Carbohydrate (%)

50.1 ± 13.2

9.7 - 73.5

Protein (%)

18.4 ± 5.1

12.2 - 30.0

Fat (%)

31.0 ± 12.3

8.9 - 61.0

Saturated Fat (%)

8.8 ± 4.2

2.3 - 19.0

Alcohol

1.4 ± 2.9

0.0 - 13.3

Cholesterol (mg)

206 ± 161

30 – 809

Fiber (gm)

24.8 ± 11.2

7.1 - 53.9

Sodium (mg)

2594 ± 1082

595 – 4816

Calcium (mg)

796.1±355.9

83.7-1653.3

mg = milligrams
g = grams
*
= exceeds recommendations
** = below recommendations
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CR Patient Survey
Upon completing CR, Group B patients gave very positive ratings when asked if having an RD
available was helpful (8.7±1.48 out of 10). Patients also indicated that they were making healthier
food choices after interacting with the RD (8.1±1.29 out of 10).
Exercise Physiologist Survey
Upon completion of the study, EPs rated the overall value of having an RD present as part of the CR
team very favorably (9.8 out of 10), (Figure 3).

Figure 3 Attitude of cardiac rehabilitation patients regarding the benefit of mini-nutrition counseling
provided by an RD and value of RD in rehabilitation as viewed by EP’s
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Chapter 5
Discussion
In 1994, the AHA declared that cardiac rehabilitation should not be limited to an exercise training
program but should also include multifaceted strategies aimed at reducing modifiable risk factors for
CVD (6,49). In addition to exercise training, a comprehensive secondary prevention program for
cardiac patients requires aggressive reduction of risk factors through nutritional counseling, weight
management, and adherence to prescribed drug therapy (3,5,9,30,31).
Lipid Management
In response to evidence that cholesterol medications decrease morbidity and mortality, the
National Cholesterol Education Program (NCEP) released its third Adult Treatment Report in 2001.
This report recommended a low-density lipoprotein concentration lower than 100 mg/dl for all
patients with coronary artery disease (49). The work from the Scandinavian Simvastatin Survival
Study Group demonstrated a 22% to 42% reduction in risk of fatal CHD with the use of statin drug
therapy. This supports the NCEP ATP III recommendations that patients with CHD and other
forms of arteriosclerosis should be treated in order to achieve an LDL level of 100 mg/dl (31,32, 33).
These findings were consistent with results from Group A and B patients whose LDL was below 100
mg/dl prior to starting CR.
In the current study, no improvement was noted in serum lipid biomarkers when RD support was
provided to Group B patients. It is suggested that the clinicians who were treating these patients were
proactive in identifying patients at high risk for CHD and, therefore aggressively treated them to target
lipid levels. In addition to current first-line statin therapy, other treatment options are also available,
including combination therapies with bile acid sequestrants, niacin, and plant stanols.
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Weight Management

In the present study, while only modest weight loss was achieved in Group B patients, the loss was
statistically significant. In the vast majority of studies which have assessed changes in body weight as a
result of CR interventions, minimal to modest reductions in weight (1-5%) were reported. Lavie and
Milani (54) studied the clinical and metabolic profiles of 588 CAD patients (40% obese) who
participated in a 12-week CR program and who showed an average weight loss of 5%. Bader et al.
(4,36) examined the clinical and metabolic outcomes for 449 consecutive cardiac rehabilitation patients
who were stratified according to the NHLBI weight classifications: normal (BMI 18-24.9 kg/m2),
overweight (BMI 25-29.9 kg/m2), class I/II obese (BMI 30-39.9 kg/m2), and class III morbidly obese
(BMI > or = 40 kg/m2). After 10 weeks, all groups had a significant exercise capacity, and on average
obese patients in each category lost weight (Class I/II lost 4 lbs and Class III lost 12 lbs).
Savage et al. (8) examined the effects of a structured behavioral weight loss program that
incorporated behavior modification principles which were designed to have an impact on the body
weights and lipid profiles of 82 patients, 27 of whom received intervention and 55 of whom
composed the CR control group. The results showed that the intervention group experienced
reductions in body weight, BMI, and total cholesterol, when compared with the control group. There
was an average weight reduction of 4.3% in the intervention group, as compared to a 1.7% weight
reduction in the control group. These findings were similar to the findings of Bader et al. (4), who
also did not reach the initial target weight loss of 10% as recommended by the NHLBI guidelines (36).
More importantly, these studies demonstrated that CR programs have not been successful in terms of
weight loss. Thus, the current findings of this study are in accordance with previous studies in the CR
literature.
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In the present 6 month study, many patients entering CR were unwilling or unready to commit to
making significant changes in their eating style. It is possible that additional changes in eating or
cooking habits or the thought of trying to lose weight was too overwhelming for some patients.
However, other patients embraced the need to make improvements in their diet or quit smoking and
committed themselves to making the necessary lifestyle changes to improve their health.
The Role of a Dietitian in CR and In Helping Patients Increase Their Nutrition Knowledge and
Confidence
Nutrition services offered by RD’s can include providing nutrition pamphlets, one-on-one
nutrition counseling, group nutrition classes, guest lectures on nutrition, and cooking demonstrations.
Cavallaro and colleagues (2) found there was a greater variety of a nutrition services offered in cardiac
rehabilitation programs when there was an RD who was involved in CR sessions. In CR sessions that
did not have an RD present, EP’s and registered nurses provided limited nutrition services.
Improved dietary choices when dining out and patient’s self-confidence in adhering to a serum
lipid-lowering diet after nutrition education was provided were noted in a study by Timlin et al. (41).
Patients indicated that they were most confident in knowing which foods to purchase and eat and that
they were better able to decrease dietary fat, cholesterol, and egg yolks eaten per week and were able to
remain on a healthy diet by themselves after receiving nutrition education classes. This concurs with
results from a study completed by Delahanty et al. (42), which suggested that MNT provided by RDs
is a reasonable investment of resources because it results in significantly higher patient satisfaction
levels when it comes to understanding lifestyle and eating habits and knowledge related to
cholesterol’s role in CHD, and their ability to manage cholesterol levels as well as eating habits when
compared to MNT provided by physicians and other healthcare professionals.
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At the completion of this study, the EP’s were surveyed to provide feedback of the experience they
had with an RD present in the CR sessions. They indicated it was beneficial for the CR patients to
have access to an RD while they attended CR sessions. The EP’s expressed the importance of
patients receiving nutrition information from an RD which enabled the EP’s to focus on training and
monitoring patients on cardiovascular exercise equipment and strength training.
Dietary Intake at the Start of CR

As patients entered CR in the present study, the majority reported consumption of a diet that had a
nutrient composition which corresponded to a typical American diet with levels of fat consumption at
more than 30% of total calories (33). Patient food records also indicated they were consuming an
average of 206 mg of dietary cholesterol/day. Saturated fat intake was also higher than recommended,
while calcium intake was lower than recommended.
Delahanty and colleagues (42) reported in their study that patients assigned to an RD for
consultation as well as medical nutrition therapy (MNT) achieved and sustained an 8% decrease in
total dietary fat intake (from 32 % to 24%) and a 4% decrease in saturated fat intake (from 11% to
7%), which was statistically significant at both 3 and 6 months following MNT. Unfortunately, similar
follow-up data in the present study were unavailable due to the lack of patient participation.
Conclusions
The typical American is exposed daily to information from a variety of sources regarding new
findings related to CVD. Some press releases have made claims of a “wonder” or “miracle” food;
others have reported about the dangers of particular foods. It is understandable that the American
public is confused and therefore prone to making misinformed decisions regarding their food
selections. Individuals need help sifting through the current popular fad diets or lifestyle
recommendations that are running rampant in the lay press. There are no easy answers on how to
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help patients improve their diet and lifestyle in regard to the prevention of CVD. Registered
Dietitians are ideally trained to implement change in dietary intake. They can help clarify and identify
the best approaches in regard to diet modification, by gradually introducing diet modifications.
The findings of this pilot study demonstrated a positive association between CR patients’ health
related outcomes and the presence of an RD in a Phase 2 CR program. Short weekly interactions
between patients and an RD showed improvements in patients’ dietary food choices and increased
self-confidence in the ability to adhere to lifestyle changes that can have a positive impact on their
health status such as body weight, blood glucose, and blood pressure.
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Appendix A – RD Encounter Form

Name ________________________
Week:
Weight:

Week:
Weight:

Week:
Weight:

Week:
Weight:

Week:
Weight:

Consults:
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Appendix B- Nutrition Knowledge Test
Nutrition and the Health of Your Heart
Test Your Nutrition Knowledge!
Please circle the letter corresponding to the best answer.
1.
a.
b.
c.
d.

To protect against heart disease, it is recommended that you eat fish:
Every day
Rarely
A few times each month
At least twice per week

2.

For a heat-healthy diet, you should consume at least:
a. 5-10 grams of fiber every day
b. 10-20 grams of fiber every day
c. 15-25 grams of fiber every day
d. 25-30 grams of fiber every day

3.

When the label of a food indicates the item is “low fat”, one serving must contain:
a. Less than 30% of the calories from fat
b. Less than 10% of the calories form fat
c. 5 or less grams of fat per serving
d. 3 or less grams of fat per serving

4.
a.
b.
c.
d.
5.

Tom is going to a steakhouse restaurant for dinner. Which cut of beef is lowest in
saturated fat?
a. Sirloin
b. Porterhouse
c. T-bone
d. Ribs

6.
a.
b.
c.
d.
7.

Even small amounts of weight loss have been shown to:
Decrease HDL
Decrease triglycerides
Increase blood pressure
Increase LDL

Which types of foods are rich in Vitamin E, an important antioxidant?
Fruits and vegetables
Whole grains and nuts
Dairy
Meat

Which of the following labels claims to be the most useful in choosing foods?
a. Reduced fat
b. Light
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c. Low fat
d. Natural
8.

Which of the following items on an ingredient list indicates that a food may contain trans
fatty acids?
a. High fructose corn syrup
b. Partially hydrogenated vegetable oil
c. Corn oil
d. Citric acid

9.

For adults who responsibly consume alcohol, the heart healthy recommendations for
daily alcohol consumption is not to exceed:
a. More than two glasses of red wine everyday
b. More than one drink per day for men and two drinks per day for women
c. More than two drinks per day for men and one drink per day for women
d. More than two drinks per day for men and women

10.

The most effective way to lower your serum cholesterol level is to decrease your intake of:
a. Cholesterol
b. Sodium
c. Sugars
d. Saturated fat

11.
a.
b.
c.
d.

Which grain is most helpful in lowering cholesterol when consumed regularly?
Oats
Rye
Rice
Wheat

a.
b.
c.
d.

Which food is high in sodium?
8 oz milk
1 oz processed American cheese
3 oz chicken breast
1 cup oatmeal

12.

13.

Janet is told by her doctor that she should lose weight to protect herself against heart
disease. The best way for Janet to lose weight is:
a. To skip lunch and to park her car at the back of the parking lot at work so she has to
walk.
b. To learn to make healthier food choices and to begin exercising most days each week.
c. To maintain her current food intake habits but begin exercising for at least one hour each
day.
d. To learn to make healthier food choices and maintain her current level of activity.

14.

Which cheese has the lowest amount of saturated fat and cholesterol?
a. Processed American
b. Part-skim mozzarella
c. Swiss
36

d. Cheddar
15.
a.
b.
c.
d.

Which source of protein is lowest in cholesterol?
Baked pork loin
Baked skinless turkey breast
Broiled beef sirloin
Black beans

a.
b.
c.
d.

Cholesterol is generally found in:
Fruits and vegetables
Oats and wheat bran
Meat and dairy
Coconut and palm oil

16.

17.

Folate has been shown to decrease harmful homocysteine levels in the blood. The
recommended intake of folate is 400 micrograms per day. Which is a good source of folate?
a. ½ cup boiled spinach
b. 3 oz beef loin
c. 1 oz. natural cheese
d. 1 oz. cashews

18.
a.
b.
c.
d.

Which of the following snack foods is likely to contain trans fatty acids?
Natural peanut butter
Orange sherbet
Tomato salsa
Wheat snack crackers

19.

Mary has high triglycerides. Which of the following may help Mary lower her
triglycerides?
a. Drinking two glasses of red wine each day
b. Eating less pastries, ice cream, soda pop and fruit juice
c. Choosing fat free cookies
d. Eating fewer eggs

20.

Which of the following terms on a label is most useful for choosing a food for a
cholesterol-lowering diet?
a. Made from turkey
b. No cholesterol
c. Dietetic
d. Low saturated fat

21.

Which of the following is a risk factor for heart disease?
a. Having blood pressure 120/80
b. Having a parent who had a heart attack at age 54
c. Having an HDL of 60 mg/dl
d. Having and LDL of 98 mg/dl
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22.

The recommended intake of dietary sodium for the general population is:
a. Less than 15,000 mg per day
b. Less than 5,000 mg per day.
c. Less than 2,400 mg per day.
d. Less than 1,200 mg per day.

23.
a.
b.
c.
d.

Which of the following fast food choices has the least amount of fat?
Regular hamburger
A fried fish sandwich
A fried chicken sandwich
A regular cheese burger

24.

Which of the following sandwiches has the most saturated fat?
a. Peanut butter and jelly
b. Turkey bologna and natural cheese
c. Tuna fish salad
d. Turkey breast and processed cheese

25.

Which of the following accurately describes a serving of alcohol?
a. 5 ounces of wine or 12 ounces of beer or 1 ½ ounces of 80 proof liquor
b. 7 ounces of wine or 14 ounces of beer or 2 ounces of 80 proof liquor
c. 5 ounces of wine or 12 ounces of beer or 1 ½ ounces of 100 proof liquor
d. 7 ounces of wine or 14 ounces of beer or 2 ounces of 100 proof liquor.

26.

Peter had salad with spinach, sprouts, avocado, olives, tomatoes, walnuts, radishes, and
Italian dressing. How many sources of added fats did he have?
a. 2
b. 3
c. 4
d. 5

27.
a.
b.
c.
d.

Which of the following seafood items has the most omega 3 fatty acids?
Orange Roughy
Salmon
Shrimp
Ocean perch

28.

Which has the most cholesterol-lowering fiber?
a. 1 slice whole wheat brad
b. 1 corn tortilla
c. 1 cup kidney beans
d. 1 banana

29.

Betty is going to an Italian restaurant for dinner. Which main course is lowest in saturated
fat?
a. Pasta with white alfredo sauce
b. Lasagna
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c. Cheese ravioli
d. Pasta with red clam sauce
30.

High blood pressure is a risk factor for heart disease. There are many ways to lower
blood pressure through nutrition, including:
a. Increase fat intake
b. Increase sodium intake
c. Decrease dairy intake
d. Eat 8-10 servings of fruits and vegetables each day

31.
a.
b.
c.
d.

Palm and coconut oils are high in:
Saturated fat
Polyunsaturated fat
Cholesterol
Monounsaturated fat

a.
b.
c.
d.

Which of the following has the most calories?
1 gram of carbohydrates
1 gram of protein
1 gram of fat
1 gram of fiber

32.

33.

Which of the following is lowest in saturated fat and trans fat?
a. Oleo
b. Stick margarine
c. Soft margarine
d. Shortening

34.
a.
b.
c.
d.

Which meat is lowest in fat?
Ground hamburger
Porterhouse steak
Round steak
Corned beef

a.
b.
c.
d.

Which has the most fiber in an average serving?
Marinated flank steak
Vegetarian chili
Turkey meatloaf
Corned beef

35.

36.

Janet’s blood test has indicated that she has high LDL-cholesterol and low HDLcholesterol. Which of the following is the best oil for Janet to use in cooking?
a. Canola oil
b. Sunflower oil
c. Soybean oil
d. Liquid margarine
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37.

Combination of mildly elevated factors can result in Metabolic Syndrome which indicates
increased risk for heart disease. Which is not a symptom of Metabolic Syndrome?
a. Waist circumference of 43 inches
b. Triglycerides at 155 mg/dl
c. HDL cholesterol at 55 mg/dl
d. Fasting blood glucose of 115

38.

You may want to schedule an appointment with a University of Michigan Cardiovascular
Center Nutritionist if:
a. You still have questions about which foods are the best choices for a heart healthy diet.
b. You knew many of the answers on the test but are having trouble incorporating changes
into your lifestyle
c. You aren’t enjoying your heart healthy diet.
d. All of the above.
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Appendix C – 3-Day Food Record
Name_________________________
Date__________________________
Time

Amount

Food
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Feelings/Emotions

Appendix D – Nutrition and Cardiac Rehab Graduation Questionnaire

Name________________________
Date_________________________
Nutrition and Cardiac Rehab
Graduation Questionnaire

1.

How strongly do you agree with the following statement:
After completing cardiac rehab, I am making healthier food choices.

1
Low

2

3

4

5
Moderate

6

7

8

9

10
High

Comments:

2.

1
Not
Helpful

How helpful was it having a dietitian available to answer your nutrition questions while
you were in cardiac rehab?

2

3

4

5
Moderately
Helpful

6

Comments:
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7

8

9

10
Highly
Helpful

Appendix E – Exercise Physiologists Evaluation of Dietitian in
the Cardiac Rehabilitation Clinic
Evaluation of the Dietitian in the Cardiac Rehab Clinic
Please take a few minutes to fill out the following questions to evaluate the benefits and effectiveness
of having a dietitian in the cardiac rehab clinic.
1.

What were the benefits for the rehab patients of having a dietitian in the rehab clinic for
the past 5 months?
1._____________________________________________________________________
2._____________________________________________________________________
3._____________________________________________________________________

2.

What were the benefits for the exercise physiologists of having a dietitian in the rehab
clinic for the past 5 months?
1._____________________________________________________________________
2._____________________________________________________________________
3._____________________________________________________________________

3.

What other things can be incorporated in the rehab setting to improve patient education
with nutrition? (ie. mini-teaches, demonstrations, nutrition handouts).
1._____________________________________________________________________
2._____________________________________________________________________
3._____________________________________________________________________

4.
1
Not
Helpful

Please rate the over all value of having a dietitian in rehab clinic 2 days a week:
2

3

4

5
Moderately
Helpful

6
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7

8

9

10
Highly
Helpful

